Use of il-20 antagonists for treating rheumatoid arthritis...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/7088 (2006.01) A61P 19/10 (2006.01)

Patent

CA 2739794

The invention features methods and compositions for preventing or treating rheumatoid arthritis and osteoporosis by administering an antagonist of IL-20. The IL-20 antagonist may be an anti- IL-20 antibody, such as mAB 7E, that is capable of binding human IL-20 and blocking IL-20 interaction with its receptors.

La présente invention concerne des procédés et des compositions pour prévenir ou traiter la polyarthrite rhumatoïde et lostéoporose par administration dun antagoniste dIL-20. Lantagoniste dIL-20 peut être un anticorps anti-IL-20, tel que mAB 7E, qui est capable de se lier à IL-20 humain et bloquer linteraction dIL-20 avec ses récepteurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of il-20 antagonists for treating rheumatoid arthritis... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of il-20 antagonists for treating rheumatoid arthritis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of il-20 antagonists for treating rheumatoid arthritis... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1871929

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.